Publication Name	World Journal of Hematology
Manuscript ID	22071
Country	United States

Received	2015-08-12 09:15
Peer-Review Started	2015-08-13 14:22
To Make the First Decision	2015-09-17 13:35
Return for Revision	2015-09-19 15:14
Revised	2015-10-24 01:23
Second Decision	2015-12-24 17:44
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-01-07 16:26
Articles in Press	2016-01-07 16:26
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-01-19 20:10
Publish the Manuscript Online	2016-01-28 15:54

ISSN	2218-6204 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Hematology
Manuscript Type	Minireviews
Article Title	Advances and perspectives on cellular therapy in acquired bone marrow failure diseases
Manuscript Source	Invited Manuscript
All Author List	Xiao-Shen Sun, Xin Liu, Kai-Lin Xu, Allshine Chen, Witold B Rybka and Jeffrey J Pu
Funding Agency and Grant Number	Funding Agency Grant Number AA and MDSIF research grant to Pu JJ 146818 American Cancer Society grant to Pu JJ 124171-IRG-13-043-02 Pennsylvania State University College of Medicine research grant (to Pu JJ)
Corresponding Author	Jeffrey J Pu, MD, PhD, Penn State Hershey Cancer Institute, Penn State College of Medicine, H064, PO Box 850, 500 University Drive, Hershey, PA 17033, United States. jeffreypu@hmc.psu.edu
Key Words	Bone marrow failure diseases; Aplastic anemia; Cellular therapy; Stem cell transplantation; Paroxysmal nocturnal hemoglobinuria; Myelodysplastic syndrome
Core Tip	Stem cell transplantation is the only method can cure acquired bone marrow failure diseases (ABMFD). However, due to the high mortality rate of stem cell transplantation itself, this method is not usually used as the first line treatment for ABMFD. With the advance of current cellular therapy technology, it is becoming possible to cure ABMFD without significant treatment related complications.
Publish Date	2016-01-28 15:54
Citation	Sun XS, Liu X, Xu KL, Chen A, Rybka WB, Pu JJ. Advances and perspectives on cellular therapy in acquired bone marrow failure diseases. World J Hematol 2016; 5(1): 31-36
URL	http://www.wjgnet.com/2218-6204/full/v5/i1/31.htm
DOI	http://dx.doi.org/10.5315/wjh.v5.i1.31

Full Article (PDF)	WJH-5-31.pdf
Full Article (Word)	WJH-5-31.doc
Manuscript File	22071-Review.docx
Answering Reviewers	22071-Answering reviewers.pdf
Audio Core Tip	22071-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	22071-Conflict-of-interest statement.pdf
Copyright License Agreement	22071-Copyright assignment.pdf
Peer-review Report	22071-Peer-review(s).pdf
Scientific Misconduct Check	22071-Scientific misconduct check.pdf
Scientific Editor Work List	22071-Scientific editor work list.pdf